Y Intercept (Hong Kong) LTD Bausch Health Companies Inc. Transaction History
Y Intercept (Hong Kong) LTD
- $1.27 Billion
- Q1 2024
A detailed history of Y Intercept (Hong Kong) LTD transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 105,765 shares of BHC stock, worth $737,182. This represents 0.09% of its overall portfolio holdings.
Number of Shares
105,765
Previous 146,200
27.66%
Holding current value
$737,182
Previous $1.17 Million
4.27%
% of portfolio
0.09%
Previous 0.11%
Shares
5 transactions
Others Institutions Holding BHC
# of Institutions
281Shares Held
278MCall Options Held
21.5MPut Options Held
21.8M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$242 Million3.29% of portfolio
-
Goldentree Asset Management LP New York, NY27.6MShares$193 Million23.66% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$184 Million20.29% of portfolio
-
Franklin Resources Inc San Mateo, CA15.9MShares$110 Million0.06% of portfolio
-
National Bank Of Canada15.7MShares$109 Million0.29% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.52B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...